Head-to-head · WeighScore
EverSlim vs VevaRX
By GLP-1 ScorecardUpdated
Score comparison
EverSlim has the higher recorded score — 73.5/100 to 54.7/100.
EverSlim grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. EverSlim is a US telehealth program selling doctor-prescribed compounded GLP-1 medication delivered to the door, with compounded semaglutide from $117 a month and compounded tirzepatide from $140 a month.
Before you choose
Before comparing the headline prices, the EverSlim review and the VevaRX review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, Alternate Health Club vs EverSlim and HealthRX vs VevaRX compare each of them with another graded program, and the list of alternatives to EverSlim ranks the programs closest to EverSlim on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the WellMedr review covers one graded close to these two, at 63.2/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | EverSlim | VevaRX |
|---|---|---|
| WeighScore | 73.5/100 | 54.7/100 |
| Grade | C | C |
| Site position | #74 | #484 |
| Semaglutide | $117/mo (compounded) | $120/mo month-to-month ($267 per 3 months; compounded) |
| Tirzepatide | $140/mo (compounded) | $189/mo month-to-month ($447 per 3 months; compounded) |
| Coverage | All 50 states | 36 states |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Strengths
- Transparent flat pricing from 127 dollars a month for compounded semaglutide; medication, provider visit, and shipping included with no insurance.
- Names its pharmacy partners (EPIQ Scripts, Foothills, Emerald) and DrTelx medical group; LegitScript-approved and NABP-accredited.
- Available in all 50 states and DC, with asynchronous care in 44 states and live-visit access in the rest.
- Offers both semaglutide and tirzepatide, plus care-team messaging between visits.
What to consider
- No price tiers are published anywhere: /pricing is a 404, the footer pricing link is a same-page anchor, and the checkout is behind a login, so what a titrated dose costs is unknowable before signing up
- Cancellation requires at least 72 hours' notice before the next billing date, or the subscription renews for another cycle
- Asynchronous care covers 44 states; DC, Kansas, Louisiana, Mississippi, New Mexico, Rhode Island and West Virginia require a live video consult
- Marketing says 'No membership' while the cancellation policy repeatedly calls it a membership and a subscription
- Compounded semaglutide and tirzepatide are not FDA-approved finished products
Strengths
- Publishes an exact 36-state list by name rather than a nationwide claim it then hedges
- States what the three-month figure covers — medication, supplies and the provider visit — and includes free two- to three-day shipping
- Unlimited physician access and a 24/7 care team are described as inside the program price
- Prices its peptide products openly beside the GLP-1 lines
What to consider
- Tirzepatide is $189 month-to-month or $447 for three months on auto-renewal
- The semaglutide page still carries an older $189 monthly and $399 three-month block that contradicts its $120 and $267 plan cards
- The semaglutide page carries four prices, two of which belong to tirzepatide
- Follow-up consultations are priced separately at $299 and $399, which the program pages do not mention
- NAD+ is priced three different ways on one page, at $399, $447 and $267
- Another company's domain appears in VevaRX's own Terms, in the transaction currency clause
- The contact page FAQ is a different product's copy and gives dosing instructions for a powdered drink under the question of how to take semaglutide or tirzepatide
- Two opposite return policies are live, and no pharmacy, compounding class, clinician or medical group is named anywhere
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.